<DOC>
	<DOC>NCT00205777</DOC>
	<brief_summary>The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.</brief_summary>
	<brief_title>Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Must be at least 2 years postmenopausal Osteoporotic subjects without vertebral fracture who meet BMD criteria, or Osteoporotic subjects with vertebral fracture Diseases that may affect bone metabolism Vasomotor symptoms requiring treatment Known history or suspected cancer of the breast Active or past history of venous thromboembolic events</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Postmenopause</keyword>
</DOC>